Vaccination against murine γ-herpesvirus infection

Viral Immunology

Volumn 14, Issue 3, 2001, Pages 217-226

  Woodland, D L ^a   Usherwood, E J ^a   Liu, L ^a   Flano E ^a   Kim, I J ^a   Blackman, M A ^a  

^a TRUDEAU INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERPES; HERPES VIRUS; INFECTION PREVENTION; LATENT PERIOD; NONHUMAN; REVIEW; SPLENOMEGALY; VACCINATION;

ANIMALIA; DNA VIRUSES; HERPES; HERPESVIRIDAE; MURID HERPESVIRUS 4; MURINAE; MURINE HEPATITIS VIRUS;

EID: 0034849740     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/088282401753266747     Document Type: Review

References (43)

1. Murine γ-herpesvirus-68: A mouse model for infectious mononucleosis?
2. An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3)
3. + T cells in acute infectious mononucleosis
4. + T cells during the primary immune response to Epstein-Barr virus in vivo
5. + T cells
6. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
7. CD4+ T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma
8. Quantitative analysis of the acute and long-term CD4+ T-cell response to a persistent gammaherpesvirus
9. Apparent MHC-independent stimulation of CD8+ T cells in vivo during latent murine gammaherpesvirus infection
10. Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells
11. Latent murine γ-herpsviruses infection is established in activated B cells, dendritic cells, and macrophages
12. Analysis of virus-specific CD4+ T cells during long-term gammaherpesvirus infection
13. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia
14. + T cells that persist in the lungs
15. Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells
16. Murine gammaherpesvirus M2 gene is latency-associated and its protein a target for CD8+ T lymphocytes
17. Epstein-Barr virus and its replication
18. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1
19. Lytic cycle T cell epitopes are expressed in two distinct phases during MHV-68 infection
20. T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice
21. Human CD4+ T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1
22. Identification of human herpesvirus 8-specific cytotoxic T-cell responses
23. Epstein-Barr virus
24. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection
25. Regression of a murine gammaherpesvirus 68-positive B-cell lymphoma mediated by CD4 T lymphocytes
26. Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus
27. Stimulation via CD40 can substitute for CD4 T cell function in preventing reactivation of a latent herpesvirus
28. Analysis of murine gammaherpesvirus-68 transcription during lytic and latent infection
29. Changing patterns of dominance in the CD8+ T cell response during acute and persistent murine gamma-herpesvirus infection
30. A gamma-herpesvirus sneaks through a CD8+ T cell response primed to a lytic-phase epitope
31. Immunological control of a murine gamma-herpesvirus independent of CD8+ T cells
32. Murine gamma-herpesvirus 68 glycoprotein 150 protects against virus- induced mononucleosis: A model system for gamma-herpesvirus vaccination
33. Lung epithelial cells are a major site of murine gammaherpesvirus persistence
34. Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68
35. Virological and pathological features of mice infected with murine gamma-herpesvirus 68
36. Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo
37. Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: Role for a viral superantigen?
38. Enumeration of antigen-presenting cells in mice infected with Sendai virus
39. Control of gammaherpesvirus latency by latent antigen-specific CD8+ T cells
40. Latent antigen vaccination in a model gammaherpesvirus infection
41. Three distinct regions of the murine gamma-herpesvirus 68 genome are transcriptionally active in latently infected mice
42. Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68
43. Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells